Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Uranium Royalty (UROY) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Uranium Royalty (UROY) over the last 4 years, with Q4 2025 value amounting to $1.3 million.

  • Uranium Royalty's Net Income towards Common Stockholders rose 53665.72% to $1.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $309100.7, marking a year-over-year decrease of 9089.61%. This contributed to the annual value of -$4.0 million for FY2025, which is 15508.47% down from last year.
  • Latest data reveals that Uranium Royalty reported Net Income towards Common Stockholders of $1.3 million as of Q4 2025, which was up 53665.72% from $1.1 million recorded in Q3 2025.
  • Over the past 5 years, Uranium Royalty's Net Income towards Common Stockholders peaked at $2.7 million during Q2 2024, and registered a low of -$2.3 million during Q4 2022.
  • Its 4-year average for Net Income towards Common Stockholders is -$14533.3, with a median of -$528331.7 in 2024.
  • Within the past 5 years, the most significant YoY rise in Uranium Royalty's Net Income towards Common Stockholders was 53665.72% (2025), while the steepest drop was 15110.74% (2025).
  • Uranium Royalty's Net Income towards Common Stockholders (Quarter) stood at -$2.3 million in 2022, then skyrocketed by 173.61% to $1.7 million in 2023, then plummeted by 116.8% to -$289986.3 in 2024, then skyrocketed by 536.66% to $1.3 million in 2025.
  • Its Net Income towards Common Stockholders stands at $1.3 million for Q4 2025, versus $1.1 million for Q3 2025 and -$766677.0 for Q2 2025.